Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;78:154-160

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, D. R.
Right arrow Articles by Freeman, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, D. R.
Right arrow Articles by Freeman, G. L.
(Circulation Research. 1996;78:154-160.)
© 1996 American Heart Association, Inc.


Articles

Tumor Necrosis Factor-{alpha} Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs

David R. Murray, Gregory L. Freeman

From the Department of Medicine, University of Texas Health Science Center at San Antonio, and the Audie L. Murphy Memorial Veterans Hospital, San Antonio, Tex.

Correspondence to David R. Murray, MD, Medicine/Cardiology, 7703 Floyd Curl Dr, San Antonio, TX 78284.

Abstract Tumor necrosis factor-{alpha} (TNF-{alpha}) likely plays a role in the pathophysiology of myocardial depression observed in septic shock. To evaluate the hemodynamic effects of TNF-{alpha} in vivo while eliminating the influence of altered sympathetic tone, eight conscious chronically instrumented dogs were studied after pretreatment with propranolol (2 mg/kg) and atropine (2 mg). Using three sets of piezoelectric crystals to measure left ventricular (LV) volume and LV manometers to measure pressure, we determined load-independent parameters of LV systolic performance before, during, and after infusion of recombinant human TNF-{alpha} (rhTNF-{alpha}, 40 µg/kg for 1 hour). Plasma was analyzed for epinephrine and norepinephrine. Between 1 and 7 hours of exposure, rhTNF-{alpha} induced significant increases in circulating catecholamines. Norepinephrine rose from 268.6±47.2 to 426.2±87.0 pg/mL (P<.05) at 1 hour and peaked at 921.2±156.8 pg/mL (P<.001) at 4 hours after initiating rhTNF-{alpha} treatment. Similarly, epinephrine increased from 130.2±30.9 to 884.5±210.2 pg/mL (P<.05) at 1 hour and peaked at 3195.3±476 pg/mL (P<.001) at 4 hours. Before the surge of circulating catecholamines and despite complete ß-adrenergic blockade, rhTNF-{alpha} induced a 7% to 40% increase in LV contractile performance during the 60-minute infusion. After this initial positive inotropic effect, rhTNF-{alpha} treatment led to precipitous systolic dysfunction between 2 and 7 hours of exposure; this myocardial depressant effect persisted at 25 hours. LV systolic performance declined to 19% to 35% of baseline values, depending on the specific contractile parameter evaluated. We conclude that rhTNF-{alpha} affects LV systolic function in a time-dependent biphasic manner. Increases in circulating catecholamines after rhTNF-{alpha} infusion cannot account for the early improvement in LV systolic performance.


Key Words: cytokine • left ventricular function • septic shock • norepinephrine • epinephrine




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
O. J. Liakopoulos, N. Teucher, C. Muhlfeld, P. Middel, G. Heusch, F. A. Schoendube, and H. Dorge
Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 263 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. C. Mehra, V. S. Ramgolam, and J. R. Bender
Cytokines and cardiovascular disease
J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. D. Prabhu
Cytokine-Induced Modulation of Cardiac Function
Circ. Res., December 10, 2004; 95(12): 1140 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Coimbra, A. Razuk-Filho, M. M. Yada-Langui, and M. Rocha-e-Silva
Intraarterial Pulmonary Pentoxifylline Improves Cardiac Performance and Oxygen Utilization After Hemorrhagic Shock: A Novel Resuscitation Strategy
Anesth. Analg., May 1, 2004; 98(5): 1439 - 1446.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Cailleret, A. Amadou, N. Andrieu-Abadie, A. Nawrocki, C. Adamy, B. Ait-Mamar, F. Rocaries, M. Best-Belpomme, T. Levade, C. Pavoine, et al.
N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-{alpha} on Calcium Transients and Contraction in Adult Rat Cardiomyocytes
Circulation, January 27, 2004; 109(3): 406 - 411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz
Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R463 - R469.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. R. Murray and G. L. Freeman
Proinflammatory Cytokines: Predictors of a Failing Heart?
Circulation, March 25, 2003; 107(11): 1460 - 1462.
[Full Text] [PDF]


Home page
ChestHome page
D. R. Murray
What Is "Heart Rate Variability" and Is It Blunted by Tumor Necrosis Factor?
Chest, March 1, 2003; 123(3): 664 - 667.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. D. Raeburn, C. M. Calkins, M. A. Zimmerman, Y. Song, L. Ao, A. Banerjee, A. H. Harken, and X. Meng
ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R477 - R486.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C G Densem, I V Hutchinson, N Yonan, and N H Brooks
Tumour necrosis factor {alpha} gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?
Heart, February 1, 2002; 87(2): 153 - 155.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Wada, K. Saito, T. Kanda, I. Kobayashi, H. Fujii, S. Fujigaki, N. Maekawa, H. Takatsu, H. Fujiwara, K. Sekikawa, et al.
Tumor Necrosis Factor-{{alpha}} (TNF-{{alpha}}) Plays a Protective Role in Acute Viral Myocarditis in Mice : A Study Using Mice Lacking TNF-{{alpha}}
Circulation, February 6, 2001; 103(5): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Horton, D. Maass, J. White, and B. Sanders
Nitric oxide modulation of TNF-alpha -induced cardiac contractile dysfunction is concentration dependent
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1955 - H1965.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. R. Murray, S. D. Prabhu, and B. Chandrasekar
Chronic {beta}-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression
Circulation, May 23, 2000; 101(20): 2338 - 2341.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. R. Murray, S. D. Prabhu, and G. L. Freeman
Hemodynamic effects of nitric oxide synthase inhibition at steady state and following tumor necrosis factor-{alpha}-induced myodepression
Cardiovasc Res, December 1, 1999; 44(3): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Li, B. Yang, and J. L. Mehta
Tumor necrosis factor-{alpha} enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C
Cardiovasc Res, June 1, 1999; 42(3): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Ishihara, J. A. Ward, O. Tasaki, B. A. Pruitt Jr., M. A. Javors, R. A. Cassidy, and D. W. Mozingo
Biphasic changes in left ventricular function during hyperdynamic endotoxemia
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1516 - R1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Meng, L. Ao, D. R. Meldrum, B. S. Cain, B. D. Shames, C. H. Selzman, A. Banerjee, and A. H. Harken
TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R502 - R508.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Bryant, L. Becker, J. Richardson, J. Shelton, F. Franco, R. Peshock, M. Thompson, and B. Giroir
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-{alpha}
Circulation, April 14, 1998; 97(14): 1375 - 1381.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr, L. H. Michael, V. V. Didenko, P. J. Hornsby, Y. Seta, H. Oral, F. G. Spinale, and D. L. Mann
Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-{alpha} Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats
Circulation, April 14, 1998; 97(14): 1382 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. R. Meldrum
Tumor necrosis factor in the heart
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Ferrari
Tumor necrosis factor in CHF: a double facet cytokine
Cardiovasc Res, March 1, 1998; 37(3): 554 - 559.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. L. Freeman, J. T. Colston, M. Zabalgoitia, and B. Chandrasekar
Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis
Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H249 - H258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Y. Li, C. F. McTiernan, and A. M. Feldman
IL-1beta alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes
Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H331 - H341.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden
Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft
Circulation, November 18, 1997; 96(10): 3436 - 3442.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
C. F. McTiernan, B. H. Lemster, C. Frye, S. Brooks, A. Combes, and A. M. Feldman
Interleukin-1ß Inhibits Phospholamban Gene Expression in Cultured Cardiomyocytes
Circ. Res., October 19, 1997; 81(4): 493 - 503.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
Z. M. N. QUEZADO, W. KARZAI, R. L. DANNER, B. D. FREEMAN, L. YAN, P. Q. EICHACKER, S. M. BANKS, J. PERREN COBB, R. E. CUNNION, M. J. N. QUEZADO, et al.
Effects of L-NMMA and Fluid Loading on TNF-induced Cardiovascular Dysfunction in Dogs
Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1397 - 1405.
[Abstract] [Full Text]


Home page
CirculationHome page
R. A. Kelly and T. W. Smith
Cytokines and Cardiac Contractile Function
Circulation, February 18, 1997; 95(4): 778 - 781.
[Full Text]


Home page
CirculationHome page
H. Senzaki, C.-H. Chen, and D. A. Kass
Single-Beat Estimation of End-Systolic Pressure-Volume Relation in Humans: A New Method With the Potential for Noninvasive Application
Circulation, November 15, 1996; 94(10): 2497 - 2506.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Amadou, A. Nawrocki, M. Best-Belpomme, C. Pavoine, and F. Pecker
Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1339 - C1347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Lang, R. A. Frost, A. C. Nairn, D. A. MacLean, and T. C. Vary
TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E336 - E347.
[Abstract] [Full Text] [PDF]